Top Markets
#1 MowCat MowCat +48.41%
#2 Bermuda Shorts Bermuda Shorts +26.38%
#3 Velvet Velvet +22.97%
#4 Fake World Assets Fake World Assets +20.31%
#5 Quack AI Quack AI +18.88%
#6 Biconomy Biconomy +18.48%
#7 Derive Derive +16.72%
#8 Perle Perle +15.52%
#9 Block Street Block Street +15.33%
#10 DUSK Network DUSK Network +14.05%
Coin of the day
MowCat MowCat
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Imunon, Inc. Imunon, Inc.

Imunon, Inc.

CLSN
Rangering i aksjer #35102
Imunon, Inc. is a biotechnology firm in the clinical development stage,... Imunon, Inc. is a biotechnology firm in the clinical development stage, dedicated to innovating and commercializing DNA-centric immunotherapies, vaccines, and targeted chemotherapy solutions. Its primary pipeline assets include GEN-1, a DNA-based immunotherapy specifically designed for the localized treatment of ovarian cancer, and ThermoDox, a unique formulation of doxorubicin encapsulated in heat-activated liposomes, currently being assessed for a variety of cancer indications. Furthermore, the company is advancing two early-phase platform technologies aimed at developing nucleic acid-based immunotherapies, vaccines, and other anti-cancer DNA or RNA treatments. Established in 1982, Imunon, Inc. maintains its operational base in Lawrenceville, New Jersey.
Aksjekurs
$1.96
Sist synkronisert: 2022-09-20
Markedsverdi
$4.46M
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel Imunon, Inc. (CLSN)

Kategori

Healthcare
Inntekter for Imunon, Inc. (CLSN)
Inntekter i Aug 2026 TTM: 0
Ifølge de nyeste økonomiske rapportene til Imunon, Inc. er selskapets nåværende inntekter (TTM) 0. I 2026 hadde selskapet inntekter på 0 lik inntektene i 2026, som var 0. Inntektene er det totale beløpet et selskap genererer fra salg av varer eller tjenester. I motsetning til fortjeneste trekkes ingen kostnader fra.
Inntektshistorikk for Imunon, Inc. fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B -
BE